Initial Statistical Considerations

  • B. G. White
Part of the Foundations of Neurology book series (FONY, volume 1)

Abstract

In the second half of the twentieth century, through their pioneering work in clinical trial and statistical methodology, individuals such as Sir A.B. Hill in the United Kingdom and J. Cornfield in the United States ushered in the randomized controlled clinical trial, a major advance in clinical medicine. Clearly, however, the comparative clinical experiment dates from much earlier; the Book of Daniel describes a comparative trial of two diets [2]. Several authors have reviewed the development of the modern clinical investigation from a statistical viewpoint [3, 4].

Keywords

Placebo Covariance Assure Stratification Verse 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tukey JW (1977) Exploratory Data Analysis. Reading, MA: Addison-Welscy.Google Scholar
  2. 2.
    Daniel I: verse 1–15.Google Scholar
  3. 3.
    Bull JP (1959) The historical development of clinical therapeutic trials. J Chronic Dis 10:218–248.PubMedCrossRefGoogle Scholar
  4. 4.
    Pollock AV (1983). Review article: Controlled clinical trials. Life Support Sys 1:227–234.Google Scholar
  5. 5.
    Fredrickson DS (1968). The field trial: Some thoughts on the indispensable ordeal. Bull NY Acad Med 44:985–993.Google Scholar
  6. 6.
    White BG (1982). Testing antiepileptic drugs in humans: Statistical considerations. In Woodbury DM, Penry JK, Pippenger CE (eds.), Antiepileptic Drugs. New York: Raven Press, pp. 159–166.Google Scholar
  7. 7.
    Bloomfield P (1976). Fourier Analysis of Time Series: An Introduction. New York: Wiley.Google Scholar
  8. 8.
    Spilker B (1984). Guide to Clinical Studies and Developing Protocols. New York: Raven Press.Google Scholar
  9. 9.
    Meincert CL (1986). Clinical Trials — Design, Conduct, and Analysis. New York: Oxford University Press.Google Scholar
  10. 10.
    Fleiss JL (1986). The Design and Analysis of Clinical Experiments. New York: Wiley.Google Scholar
  11. 11.
    Friedman LM, Furberg CD, DeMets DL (1985) Fundamentals of Clinical Trials, 2nd edition. Boston, MA: PSG.Google Scholar
  12. 12.
    Tukey J (1977). Some thoughts on clinical trials, especially problems of multiplicity. Science 198:679–684.PubMedCrossRefGoogle Scholar
  13. 13.
    Byar DP, Simon RM, et al. (1976). Randomized clinical trials: perspectives on some recent ideas. N Engl J Med 295:74–80.PubMedCrossRefGoogle Scholar
  14. 14.
    Ingelfinger FJ (1972). The randomized clinical trial (editorial). N Engl J Med 287:100–101.PubMedCrossRefGoogle Scholar
  15. 15.
    Efron B (1971). Forcing a sequential experiment to be balanced. Biometrika 58:403–417.CrossRefGoogle Scholar
  16. 16.
    Zelen M (1979). A new design for randomized clinical trials. N Engl J Med, 300:1242–1245.PubMedCrossRefGoogle Scholar
  17. 17.
    Fleiss JL (1973). Statistical Methods for Rates and Proportions. New York: Wiley.Google Scholar
  18. 18.
    Lachin JM (1981). An introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 2:93–113.PubMedCrossRefGoogle Scholar
  19. 19.
    Brown BW, Hollander M (1977). Statistics — A Biomedical Introduction. New York: Wiley.Google Scholar
  20. 20.
    Lachin J (1982). Statistical inference in clinical trials. In: Tygstrup N, Lachin JM, Juhl E (eds.), The Randomized Clinical Trials and Therapeutic Decisions. New York: Marcel Dekker, pp. 117–144.Google Scholar
  21. 21.
    Young MJ, Bresnitz EA, Strom BL (1983). Size nomograms for interpreting negative clinical studies. Ann Intern Med 99:248–251.PubMedGoogle Scholar
  22. 22.
    Blackwelder WC, Chang MC (1984). Sample size graphs for “proving the null hypothesis”. Controlled Clin Trials 5:97–105.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • B. G. White

There are no affiliations available

Personalised recommendations